tabl content supplementari inform event lead action ii health effect sick build syndrom b build relat ill 1 indoor air contamin 2 microbi contamin c environment tobacco smoke 1 pharmacokinet absorpt distribut b metabol 2 irrit 3 pulmonari effect 4 cardiovascular effect thrombu format b vascular wall injuri c possibl mechan effect acut heart effect e chronic heart effect 5 reproduct effect 6 cancer evid associ b epidemiolog experiment studi 7 genotox 8 conclus case report 1 sick build syndrom build relat ill 2 environment tobacco smoke iii exposur sourc indoor air contamin b microbi contamin c exposur studi 1 low level contamin 2 bioaerosol 3 environment tobacco smoke chemistri b human activ pattern studi use assess workplac exposur c indoor level environment tobacco smoke constitu level respir suspend particul nicotin found field studi e biomark environment tobacco smoke exposur f inadequaci gener dilut ventil address environment tobacco smoke exposur control iv preliminari quantit risk assess introduct b review epidemiolog studi publish risk estim c data sourc osha estim risk environment tobacco smoke exposur e osha risk estimates_indoor air qualiti f pharmacokinet model environment tobacco smoke exposur 1 consider select biomark environment tobacco smoke 2 cardiovascular effect 3 carcinogen 4 evalu cotinin biomark environment tobacco smoke 5 descript pharmacokinet model nicotin cotinin 6 applic pharmacokinet model environment tobacco smoke exposur estim 7 analysi uncertainti physiolog paramet b distribut paramet c kinet paramet